San Diego, CA (PRWEB) April 13, 2013
Resource4thePeople today updates the status of numerous lawsuits alleging links between Tylenol products and liver cancer by announcing that a multidistrict litigation has been created for the lawsuits in the federal court system.
The United States Judicial Panel for Multidistrict litigation recently approved a petition by plaintiffs who have filed these lawsuits and consolidated the cases before a federal judge in the Eastern District of Pennsylvania.*
The cases have been consolidated under the new case number In Re Tylenol MDL2436 U.S. District Court, Eastern District of Pennsylvania.
The action means Resource4thePeople will increase the number of attorneys investigating claims from consumers who are alleging that they suffered liver damage or failure problems because of their use of Tylenol and other acetaminophen medications.
“The consolidation of the cases means we will be receiving an increasing number of inquiries from consumers about what legal options may be available to them in connection with alleged serious liver problems that they are attributing to the use of Tylenol products,” said Resource4thePeople.
“Therefore, we are informing consumers that our team of nationwide lawyers not only will be investigating such claims, they will also be offering free consultations to consumers who believe that they may have such a claim.”
Here is part of the ruling from the judicial panel explaining the decision:*
"On the basis of the papers filed and hearing session held, we find that the actions listed on Schedule A involve common questions of fact, and that centralization in the Eastern District of Pennsylvania will serve the convenience of the parties and witnesses and promote the just and efficient conduct of the litigation.
"As stated above, the actions all involve allegations that ingesting acetaminophen– specifically, OTC Tylenol in its various forms – can cause liver injury. The actions share factual issues concerning the design, manufacture, labeling, marketing, and sale of Tylenol.
Centralization will eliminate duplicative discovery, prevent inconsistent pretrial rulings (on Daubert issues and other matters), and conserve the resources of the parties, their counsel, and the judiciary."
Resource4thePeople has discovered that many of the consumers who have made inquiries were unfamiliar with some of the possible side effects from Tylenol products that could cause liver damage or failure. These are now being detailed on the Tylenol official web site.**
Included in these details is the warning: “It is important to be aware of the ingredients I all medications that you may be taking. Acetaminophen (APAP) is a common component of many different over-the-counter and prescription medications. You should not take two or more products that contain acetaminophen at the same time. Taking more than the recommended dose (overdose) of acetaminophen may cause liver damage.”
Resource4thePeople also is informing consumers inquiring about Tylenol claims about a health update*** issued by the Food and Drug Administration that warns about liver damage due to large doses of the medication, using it with other acetaminophen-based medications or with alcohol or other drugs.
The FDA cites the dangers of liver damage or failure, kidney failure or heart problems, seizures, and death.
“These are serious health issues that -- because of the huge popularity of these drugs -- are causing widespread concern among consumers,” said Resource4thePeople “Our attorneys are now actively investigating the concerns and claims that are being alleged in increasing numbers by consumers concerned about side effects.”
Resource4thePeople also is announcing that it will continue to inform consumers who may have suffered liver damage as a result of the use of Tylenol and other acetaminophen medications about the results of an important court date involving lawsuits that have been filed so far over these claims.
“The creation of a multidistrict litigation is an important milestone in the progress of a growing number of lawsuits claiming that the use of Tylenol and other acetaminophen-based pain-killers can put patients at significantly increased risk of suffering life-threatening liver damage,” said Resource4thePeople.
“Resouce4thePeople remains committed to providing updates about the progress of this litigation and is also providing free legal consultations to individuals who may have suffered liver damage from Tylenol use. We welcome their inquiries and will investigate the merits of such cases.”
Attorneys for the plaintiffs requested that the 28 cases currently pending against McNeil PPC Inc., McNeil Consumer Healthcare and Johnson & Johnson be coordinated and consolidated at the federal courthouse in Philadelphia.
“All of the products liability cases referenced by the plaintiffs’ lawyers allege that McNeil marketed and sold its over-the-counter Tylenol products in a manner that concealed the margin of risk of liver toxicity and liver failure,” according to the filings for the petition.****
The judge assigned the cases will oversee pre-trial evidence-gathering, legal motions and settlement talks in the litigation.
Resource4thePeople said that the consultations with Tylenol liver damage allegation attorneys can provide legal options to men, women and children who allegedly have suffered liver damage or failure due to their use of Tylenol and other products containing the ingredient acetaminophen.
Legal assistance also is available to those who may have lost a loved one and may be seeking information about the facts involved in a wrongful death.